Clara Biotech, Inc, a Kansas City based biotechnology company developing its ExoRelease™ immunocapture and release platform to isolate and purify exosomes, today announced a newly appointed board director and members of its Advisory Board.
The Advisory Board comprises business leaders with extensive experience in leadership and strategic advisory roles for biotech and early-stage companies with expertise in lab tools, diagnostics, and therapeutics.
BioTools Innovator, a new program focused on accelerating life science tools and diagnostics, announced Clara Biotech as the Best Video award winner of the first BioTools Innovator program final competition. The winning company was determined by a live audience vote on October 14 at the BioTools Innovator Capstone Event in Carlsbad, Calif.
Clara Biotech also took home a $10,000 Finalist Award. BioTools Innovator received over 160 applications in this year's cycle. 23 companies were invited to pitch during the BioTools Innovator Road Tour, with 10 companies ultimately receiving a slot in the 2021 Cohort. Clara Biotech was recognized as a finalist selected from this year's BioTools Innovator Accelerator program.
The competition kicks off today, and we need your help to support our company and our dreams of enabling tomorrow’s medical breakthroughs today! In addition to winning cash awards for views and likes of our video, Clara has an opportunity to touch many exosome researchers and could potentially win up to $200k cash in the final competition.